title: Increased tissue survival in experimental skin flaps in mast cell-deficient rats.
abstract: OBJECTIVE
  The role of mast cells and their principal mediator, histamine, in surgical skin flap survival was investigated using mast cell-deficient (Ws/Ws); their congenic littermates wild-type (+/+), and Wistar rats.
  
  
  METHODS
  A standardized dorsal skin flap was raised and sutured back into position, and 6 days later the percentage of flap survival was assessed. Moreover, endogenous histamine concentration in the dorsal skin during the surgical preparation was determined using in vivo microdialysis technique together with high performance liquid chromatography-fluorometry. Accumulation of skin flap myeloperoxidase (MPO) (reflecting leucocyte recruitment) was determined spectrophotometrically.
  
  
  RESULTS
  The experimental skin flaps in genetically mast cell-deficient rats exhibited increased tissue survival and showed little accumulation of MPO and rather low and stable level of histamine output in comparison with skin flaps in the wild-type (+/+) littermates or normal Wistar rats. Antihistamine treatment inhibited but did not prevent leucocyte recruitment in the skin flaps post-surgery in +/+ and Wistar rats.
  
  
  CONCLUSIONS
  It is suggested that mast cell derived histamine plays an important role in leucocyte recruitment in skin flaps. However, mast cell-independent factors should be taken into consideration and needs further investigation as even in mast cell-deficient animals there was some accumulation of leucocytes and tissue necrosis in the skin flaps post-surgery.
authors.affiliation: Department of Physiology & Pharmacology, Karolinska Institutet, Stockholm, Sweden.
authors.forename: Y
authors.initials: Y
authors.lastname: Guo
authors.forename: L
authors.initials: L
authors.lastname: Törkvist
authors.forename: J
authors.initials: J
authors.lastname: Raud
authors.forename: P
authors.initials: P
authors.lastname: Hedqvist
mesh_terms: D000818:Animals; D002744:Chlorpheniramine / Q000494:pharmacology; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D002927:Cimetidine / Q000494:pharmacology; D005470:Fluorometry / Q000379:methods; D006632:Histamine / Q000032:analysis; D006633:Histamine Antagonists / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000502:physiology*; D017551:Microdialysis / Q000379:methods; D009195:Peroxidase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012867:Skin / Q000378:metabolism; D012879:Skin Physiological Phenomena / Q000187:drug effects; D014022:Tissue Survival / Q000187:drug effects / Q000502:physiology*
chemical_list: D006633:Histamine Antagonists; D002744:Chlorpheniramine; D002927:Cimetidine; D006632:Histamine; D009195:Peroxidase